Deciphex uses digital pathology and AI to address the pathology productivity gap
Deciphex is an Irish-based software company focused on developing digital pathology-based solutions for clinical and research pathology. Our ambition is to deliver solutions that provide tangible productivity benefits to pathologists, eliminating low-level tasks so they can focus on the critical content. We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, offering a solution to the pending challenges in supply/demand in pathology services. Deciphex plans to be at the forefront of this revolution with cleverly positioned solutions that deliver on the biggest problems facing pathology today.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 19, 2022 | Series B | $11.50M | 2 | — | — | Detail |
Jul 16, 2020 | Series A | $6.20M | 1 | — | — | Detail |
Apr 15, 2019 | Series Unknown | €2.30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
NextSteps Capital | — | Series B |
HBAN Medtech Syndicate | — | Series B |